25-hydroxyprotopanaxadiol has been researched along with Stomach Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Wang, X; Li, T; Li, Y; Yuan, WH; Zhao, YQ | 1 |
| Guo, S; Su, G; Wang, X; Zhang, X; Zhao, C; Zhao, Y | 1 |
2 other study(ies) available for 25-hydroxyprotopanaxadiol and Stomach Neoplasms
| Article | Year |
|---|---|
2-Pyrazine-PPD, a novel dammarane derivative, showed anticancer activity by reactive oxygen species-mediate apoptosis and endoplasmic reticulum stress in gastric cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Cell Line, Tumor; Cell Proliferation; Endoplasmic Reticulum Stress; Ginsenosides; Humans; Mitochondria; Oxidative Stress; Reactive Oxygen Species; Signal Transduction; Stomach Neoplasms | 2020 |
Antitumor activity of ginseng sapogenins, 25-OH-PPD and 25-OCH3-PPD, on gastric cancer cells.
Topics: Antineoplastic Agents; Caspases; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Damage; Ginsenosides; Humans; Panax; Sapogenins; Signal Transduction; Stomach Neoplasms | 2016 |